v3.26.1
Stockholder Equity (Tables)
6 Months Ended
Jun. 30, 2026
Stockholder Equity  
Schedule of stock based compensation related to stock option and RSU expected to vest present in operations

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30, 2026

 

 

June 30, 2025

 

 

June 30, 2026

 

 

June 30, 2025

 

Research and development

 

$43,862

 

 

$64,837

 

 

$82,497

 

 

$128,640

 

Compensation and related expenses

 

 

566,059

 

 

 

484,242

 

 

 

1,707,613

 

 

 

1,129,902

 

General and administrative expenses

 

 

-

 

 

 

-

 

 

 

147,237

 

 

 

-

 

Total expense

 

$609,921

 

 

$549,079

 

 

$1,937,347

 

 

$1,258,542

 

Schedule of stock option activity

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

 

 

 

Average

 

 

Aggregate

 

 

Remaining

 

 

 

 

 

Exercise

 

 

Intrinsic

 

 

Contractual

 

 

 

Shares

 

 

Price

 

 

Value

 

 

Life (Years)

 

Options outstanding at December 31, 2025

 

 

1,708,637*

 

$6.88

 

 

$272,680

 

 

 

7.28

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

(300,000)

 

 

1.13

 

 

 

-

 

 

 

-

 

Expired/forfeit

 

 

(340,395)

 

 

9.06

 

 

 

-

 

 

 

-

 

Options outstanding at March 31, 2026

 

 

1,068,242

 

 

$7.80

 

 

$14,280

 

 

 

8.36

 

Granted

 

 

683,921

 

 

 

2.43

 

 

 

-

 

 

 

-

 

Exercised

 

 

(38,921)

 

 

1.20

 

 

 

-

 

 

 

-

 

Expired/forfeit

 

 

(44,609)

 

 

12.09

 

 

 

-

 

 

 

-

 

Options outstanding at June 30, 2026

 

 

1,668,633

 

 

$5.61

 

 

$-

 

 

 

8.80

 

Options exercisable at June 30, 2026

 

 

795,562*

 

$8.00

 

 

$-

 

 

 

7.99

 

Schedule of stock option assumptions

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

Expected volatility

 

96.48- 109.66

%

 

67.81- 71.56

%

Expected term (years)

 

5.00 - 6.00

 

 

 

6.25

 

Risk-free rate

 

3.94 - 4.35

%

 

4.00 - 4.51

%

Dividend rate

 

 

0%

 

 

0%
Schedule of outstanding Unvested restricted stock

 

 

 

 

Weighted-Average

 

 

 

 

 

Grant Date

 

 

 

Amount

 

 

Fair Value

 

Unvested, December 31, 2025

 

 

593,487

 

 

$5.02

 

Vested

 

 

(166,221)

 

 

5.45

 

Forfeited

 

 

(153,545)

 

 

5.35

 

Unvested, March 31, 2026

 

 

273,721

 

 

$4.58

 

Granted

 

 

175,000

 

 

 

2.87

 

Vested

 

 

(76,802)

 

 

3.36

 

Forfeited

 

 

(444)

 

 

6.20

 

Unvested, June 30, 2026

 

 

371,475

 

 

$4.03

 

 

 

 

 

Weighted-Average

 

 

 

 

 

Grant Date

 

 

 

Amount

 

 

Fair Value

 

Unvested, December 31, 2025

 

 

271,809

 

 

$5.22

 

Forfeited

 

 

(129,914)

 

 

6.04

 

Unvested, March 31, 2026

 

 

141,895

 

 

$4.48

 

Unvested, June 30, 2026

 

 

141,895

 

 

$4.48

 

Schedule of warrant activity

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

Weighted-

 

 

 

 

Average

 

 

 

 

 

Average

 

 

Aggregate

 

 

Remaining

 

 

 

 

 

Exercise

 

 

Intrinsic

 

 

Contractual

 

 

 

Shares

 

 

Price

 

 

Value

 

 

Life (Years)

 

Warrants outstanding at December 31, 2025

 

 

877,524

 

 

$2.06

 

 

$90,917

 

 

 

3.88

 

Granted

 

 

160,000

 

 

 

7.50

 

 

 

-

 

 

 

-

 

Expired/forfeit

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Warrants outstanding at March 31, 2026

 

 

1,037,524

 

 

$2.90

 

 

$784,936

 

 

 

3.53

 

Granted

 

 

520,000

 

 

 

4.50

 

 

 

-

 

 

 

-

 

Additional warrants due to Modification (Note 5)

 

 

306,667

 

 

 

4.50

 

 

 

-

 

 

 

-

 

Expired/forfeit

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Warrants outstanding at June 30, 2026

 

 

1,864,191

 

 

$3.35*

 

$-

 

 

 

3.16

 

Warrants exercisable at June 30, 2026

 

 

1,864,191

 

 

$3.35*

 

$-

 

 

 

3.16